$T2 Biosystems(TTOO.US)$In a recent filing with the United States Securities and Exchange Commission, Nathan D. Hukill, along with associated entities including CR Group L.P. and various CRG Partners funds, reported a significant change in their beneficial ownership of T2 Biosystems, Inc. The group now collectively owns 8,853,173 shares, representing approximately 65.4% of the company's issued and outstanding common stock. This change in ownership is a result of the cancellation of outstand...
$T2 Biosystems(TTOO.US)$Reuters· 1 min ago T2 Biosystems Inc: Signed a Non-Binding Letter of Intent to Enter Into a Strategic Partnership With Eco Laboratory
$T2 Biosystems(TTOO.US)$ NEWS T2 Biosystems Announces First Quarter 2024 Financial Results T2 Biosystems, a leader in sepsis detection, announced Q1 2024 financial results, showing 25% growth in sepsis product revenue. They converted $30M debt into equity, signed key agreements, and focused on product development. 25% growth in sepsis product revenue in Q1 2024 Reduced debt by 80% compared to the prior year Signed key agreements to strengthen the balance sheet Received FDA clearances for product...
T2 Biosystems股票讨论区
T2 Biosystems Inc: Signed a Non-Binding Letter of Intent to Enter Into a Strategic Partnership With Eco Laboratory
T2 Biosystems Inc: Announced Execution of Territory Exclusive Distribution Agreement in Qatar
NEWS
T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems, a leader in sepsis detection, announced Q1 2024 financial results, showing 25% growth in sepsis product revenue. They converted $30M debt into equity, signed key agreements, and focused on product development.
25% growth in sepsis product revenue in Q1 2024
Reduced debt by 80% compared to the prior year
Signed key agreements to strengthen the balance sheet
Received FDA clearances for product...
暂无评论